GE HealthCare Reports Strong Q2 Performance in Earnings Call
In its second-quarter earnings call for fiscal year 2026, GE Healthcare reported strong performance with orders up 11% and a record backlog of $2.6 billion compared to the previous year. The company noted robust demand across all three business segments and geographies, driven by differentiated products that enhance clinical outcomes and productivity. CEO Peter Arduini highlighted progress in commercial operations and AI-enabled innovations as key contributors to growth. Revenue was led by pharmaceutical diagnostics and advanced imaging solutions, while Patient Care Solutions faced ongoing challenges despite strong order growth from new platforms and sales force realignment. The company is reviewing strategic options for this segment to maximize long-term value. CFO Jay Saccaro provided financial context in the call, with full details available in the press release and presentation slides on GE Healthcare's website.
Tickers: $GEHC